EAM
Eventide Asset Management Portfolio holdings
AUM
$6.4B
1-Year Est. Return
66.41%
This Fund
S&P 500
1 Year Est. Return
+66.41%
AUM
$6.4B
AUM Growth
+$319M
(+5.3%)
Holding
290
Top Buys
| 1 | +$43.3M | |
| 2 | +$32.9M | |
| 3 | +$30.7M | |
| 4 |
Apogee Therapeutics
APGE
|
+$27.5M |
| 5 |
Monolithic Power Systems
MPWR
|
+$26.1M |
Top Sells
| 1 | +$95.2M | |
| 2 | +$72.7M | |
| 3 | +$72.5M | |
| 4 |
Celcuity
CELC
|
+$63.7M |
| 5 |
Evolent Health
EVH
|
+$53.2M |
Sector Composition
| 1 | Healthcare | 42.37% |
| 2 | Industrials | 17.69% |
| 3 | Technology | 15.85% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Utilities | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TG Therapeutics
TGTX
$4.78B
| $21.4M | 0.33% |
716,414
-238,117
|
|
||
102
MSCI
MSCI
$42B
| $20.9M | 0.33% |
36,280
+980
|
|
||
103
Rockwell Automation
ROK
$45.8B
| $20.3M | 0.32% |
52,191
+372
|
|
||
104
Praxis Precision Medicines
PRAX
$9.34B
| $19.8M | 0.31% |
+67,100
|
|
||
|
TTAN
105
ServiceTitan Inc
TTAN
$6.78B
| $19M | 0.3% |
178,616
+169,634
|
|
||
106
American Express
AXP
$212B
| $18.6M | 0.29% |
50,106
+361
|
|
||
107
Amylyx Pharmaceuticals
AMLX
$1.67B
| $18.3M | 0.29% |
1,513,148
+648
|
|
||
108
IDEX
IEX
$15.7B
| $17.7M | 0.28% |
99,135
+2,753
|
|
||
109
Privia Health
PRVA
$2.92B
| $17.5M | 0.27% |
737,694
|
|
||
110
Vertiv
VRT
$97.5B
| $17.2M | 0.27% |
105,999
+102,447
|
|
||
111
Vital Farms
VITL
$944M
| $16.6M | 0.26% |
517,988
+1,260
|
|
||
|
EVMN
112
Evommune Inc
EVMN
$820M
| $16.5M | 0.26% |
+961,525
|
|
||
113
Broadcom
AVGO
$1.52T
| $16.4M | 0.26% |
47,308
-1,545
|
|
||
114
Baker Hughes
BKR
$64.5B
| $16M | 0.25% |
349,974
+319,345
|
|
||
115
Xylem
XYL
$31.6B
| $15.4M | 0.24% |
113,301
+453
|
|
||
|
HTFL
116
Heartflow Inc
HTFL
$1.97B
| $14.7M | 0.23% |
505,989
+421,999
|
|
||
117
Invivyd
IVVD
$477M
| $14.3M | 0.22% |
+5,809,256
|
|
||
118
Olema Pharmaceuticals
OLMA
$1.94B
| $14.2M | 0.22% |
+569,000
|
|
||
119
S&P Global
SPGI
$132B
| $14.2M | 0.22% |
26,995
+2,952
|
|
||
120
Garmin
GRMN
$48.7B
| $14.1M | 0.22% |
69,476
+51,191
|
|
||
121
Edgewise Therapeutics
EWTX
$3.22B
| $14.1M | 0.22% |
568,310
|
|
||
122
Alnylam Pharmaceuticals
ALNY
$44.2B
| $13.5M | 0.21% |
34,035
-67,704
|
|
||
123
monday.com
MNDY
$3.74B
| $13.5M | 0.21% |
91,472
-1,139
|
|
||
|
MAZE
124
Maze Therapeutics
MAZE
$2.19B
| $13.4M | 0.21% |
+324,041
|
|
||
|
BBOT
125
BridgeBio Oncology
BBOT
$802M
| $13.4M | 0.21% |
1,082,362
|
|